ApprovalTrail

Approval · Notice of Compliance 5672 · 1994

VISIPAQUE: Notice of Compliance 5672

Issued December 20, 1994

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
5672
Date
December 20, 1994
Company
Nycomed Imaging A.S.Oslo, Saone Et Loire, Norway
Product type
Nonprescription Pharmaceutical
Submission
New Drug Submission (NDS)
Submission class
Admin
Therapeutic class
Non-ionic radiographic contrast medium

Products in this notice

BrandDINStatus today
VISIPAQUE02145766Marketed
VISIPAQUE02145774Marketed

Medicinal ingredients